secwatch / observer
8-K filed May 20, 2026 12:30 UTC ticker CNMD CIK 0000816956
leadership confidence high sentiment positive materiality 0.50

CONMED appoints two new directors from J&J and Boston Scientific; Board expands to nine

CONMED Corp

item 5.02item 5.03item 5.07item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Jeff Mirviss

Director
CNMD · CONMED Corp
Effective
2026-07-01
Filed
May 20, 2026 12:30 UTC
On May 19, 2026, the Board of Directors (the “Board”) of CONMED Corporation (the “Company”) increased the size of the Board to nine directors and appointed Celine Martin and Jeff Mirviss as directors, each effective July 1, 2026.
Appointed (interim)

Kimberly Lockwood

Interim Corporate Controller and Interim Principal Accounting Officer
CNMD · CONMED Corp
Effective
2026-06-01
Filed
May 20, 2026 12:30 UTC
On May 19, 2026, the Board appointed Kimberly Lockwood as Interim Corporate Controller and Interim Principal Accounting Officer of the Company effective June 1, 2026.
Appointed

Celine Martin

Director
CNMD · CONMED Corp
Effective
2026-07-01
Filed
May 20, 2026 12:30 UTC
On May 19, 2026, the Board of Directors (the “Board”) of CONMED Corporation (the “Company”) increased the size of the Board to nine directors and appointed Celine Martin and Jeff Mirviss as directors, each effective July 1, 2026.
Source: SEC EDGAR
accession 0000816956-26-000057
view filing index on sec.gov
view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.